These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
483 related articles for article (PubMed ID: 8674469)
21. Regulation of the dopamine transporter: aspects relevant to psychostimulant drugs of abuse. Schmitt KC; Reith ME Ann N Y Acad Sci; 2010 Feb; 1187():316-40. PubMed ID: 20201860 [TBL] [Abstract][Full Text] [Related]
22. Modulation of dopamine transporter function by alpha-synuclein is altered by impairment of cell adhesion and by induction of oxidative stress. Wersinger C; Prou D; Vernier P; Sidhu A FASEB J; 2003 Nov; 17(14):2151-3. PubMed ID: 12958153 [TBL] [Abstract][Full Text] [Related]
23. Dopamine transporter glycosylation correlates with the vulnerability of midbrain dopaminergic cells in Parkinson's disease. Afonso-Oramas D; Cruz-Muros I; Alvarez de la Rosa D; Abreu P; Giráldez T; Castro-Hernández J; Salas-Hernández J; Lanciego JL; Rodríguez M; González-Hernández T Neurobiol Dis; 2009 Dec; 36(3):494-508. PubMed ID: 19766189 [TBL] [Abstract][Full Text] [Related]
24. Dopamine transport function is elevated in cocaine users. Mash DC; Pablo J; Ouyang Q; Hearn WL; Izenwasser S J Neurochem; 2002 Apr; 81(2):292-300. PubMed ID: 12064476 [TBL] [Abstract][Full Text] [Related]
26. Cocaine, metamfetamine, and MDMA abuse: the role and clinical importance of neuroadaptation. Seger D Clin Toxicol (Phila); 2010 Aug; 48(7):695-708. PubMed ID: 20849328 [TBL] [Abstract][Full Text] [Related]
27. Effects of a novel dopamine uptake inhibitor upon extracellular dopamine from superfused murine striatal tissue. Geldenhuys WJ; Bezuidenhout LM; Dluzen DE Eur J Pharmacol; 2009 Oct; 619(1-3):38-43. PubMed ID: 19686731 [TBL] [Abstract][Full Text] [Related]
28. Cocaine-induced seizures and lethality appear to be associated with distinct central nervous system binding sites. Ritz MC; George FR J Pharmacol Exp Ther; 1993 Mar; 264(3):1333-43. PubMed ID: 8450469 [TBL] [Abstract][Full Text] [Related]
29. Applications of SPECT imaging of dopaminergic neurotransmission in neuropsychiatric disorders. Kugaya A; Fujita M; Innis RB Ann Nucl Med; 2000 Feb; 14(1):1-9. PubMed ID: 10770574 [TBL] [Abstract][Full Text] [Related]
30. A cloned dopamine transporter. Potential insights into Parkinson's disease pathogenesis. Uhl GR; Kitayama S Adv Neurol; 1993; 60():321-4. PubMed ID: 8380524 [No Abstract] [Full Text] [Related]
31. Protein tyrosine kinase inhibitors alter human dopamine transporter activity in Xenopus oocytes. Doolen S; Zahniser NR J Pharmacol Exp Ther; 2001 Mar; 296(3):931-8. PubMed ID: 11181926 [TBL] [Abstract][Full Text] [Related]
32. The dopamine transporter is differentially regulated after dopaminergic lesion. Afonso-Oramas D; Cruz-Muros I; Barroso-Chinea P; Álvarez de la Rosa D; Castro-Hernández J; Salas-Hernández J; Giráldez T; González-Hernández T Neurobiol Dis; 2010 Dec; 40(3):518-30. PubMed ID: 20688165 [TBL] [Abstract][Full Text] [Related]
33. Genetic association between dopamine transporter protein alleles and cocaine-induced paranoia. Gelernter J; Kranzler HR; Satel SL; Rao PA Neuropsychopharmacology; 1994 Nov; 11(3):195-200. PubMed ID: 7865100 [TBL] [Abstract][Full Text] [Related]
34. Role of dopamine transporter imaging in routine clinical practice. Marshall V; Grosset D Mov Disord; 2003 Dec; 18(12):1415-23. PubMed ID: 14673877 [TBL] [Abstract][Full Text] [Related]
35. Amphetamine-induced loss of human dopamine transporter activity: an internalization-dependent and cocaine-sensitive mechanism. Saunders C; Ferrer JV; Shi L; Chen J; Merrill G; Lamb ME; Leeb-Lundberg LM; Carvelli L; Javitch JA; Galli A Proc Natl Acad Sci U S A; 2000 Jun; 97(12):6850-5. PubMed ID: 10823899 [TBL] [Abstract][Full Text] [Related]
36. Imaging studies on the role of dopamine in cocaine reinforcement and addiction in humans. Volkow ND; Fowler JS; Wang GJ J Psychopharmacol; 1999 Dec; 13(4):337-45. PubMed ID: 10667609 [TBL] [Abstract][Full Text] [Related]
37. Protein kinase C-mediated functional regulation of dopamine transporter is not achieved by direct phosphorylation of the dopamine transporter protein. Chang MY; Lee SH; Kim JH; Lee KH; Kim YS; Son H; Lee YS J Neurochem; 2001 May; 77(3):754-61. PubMed ID: 11331404 [TBL] [Abstract][Full Text] [Related]
38. Comparison between the decrease of dopamine transporter and that of L-DOPA uptake for detection of early to advanced stage of Parkinson's disease in animal models. Ito Y; Fujita M; Shimada S; Watanabe Y; Okada T; Kusuoka H; Tohyama M; Nishimura T Synapse; 1999 Mar; 31(3):178-85. PubMed ID: 10029235 [TBL] [Abstract][Full Text] [Related]
39. Dopamine D2 receptor regulation of the dopamine transporter expressed in Xenopus laevis oocytes is voltage-independent. Mayfield RD; Zahniser NR Mol Pharmacol; 2001 Jan; 59(1):113-21. PubMed ID: 11125031 [TBL] [Abstract][Full Text] [Related]